Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 67 | +9 |
| Shares | 5.76M | 7 | 6.74M | +986.0K (+17.1%) |
| Value | $29.3M | $36 | $52.8M | +$23.5M (+80.4%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Verition Fund Management LLC | 196,437 | $1.54M | 0.01% |
| Marshall Wace, LLP | 152,469 | $1.19M | 0.00% |
| ADAR1 Capital Management, LLC | 100,000 | $783.0K | 0.21% |
| Hudson Bay Capital Management LP | 93,204 | $729.8K | 0.01% |
| Millennium Management LLC | 67,411 | $527.8K | 0.00% |
| Lighthouse Investment Partners, LLC | 26,408 | $206.8K | 0.01% |
| American Century Companies Inc | 18,852 | $147.6K | 0.00% |
| Am Investment Strategies LLC | 12,582 | $99.0K | 0.03% |
| Sanders Morris Harris LLC | 10,000 | $78.3K | 0.01% |
| Qube Research & Technologies Ltd | 3,193 | $25.0K | 0.00% |
| Leonteq Securities AG | 500 | $3.90K | 0.00% |
| The PNC Financial Services Group, Inc. | 100 | $783 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $39 | 0.00% |
Sold out (4)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 14,285 | $72.6K |
| Advisory Services Network, LLC | 2,120 | $10.8K |
| Hazlett, Burt & Watson, Inc. | 200 | $1.00K |
| Gradient Investments LLC | 66 | $335 |
Not filed for Q1 2024 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Coppell Advisory Solutions LLC | 7 | $36 |